Business Standard

Sun Pharma at new high on FDA nod for generic version of Januvia

USFDA has granted its subsidiary, two tentative approvals for its ANDA for generic version of Januvia, Sitagliptin tablets and generic version of Glumetza, Metformin HCl extended-release tablets.

Related News

Sun Pharmaceutical Industries has moved higher by 3% to Rs 914, extending its previous day’s 2.3% gain after the company said it has received a tentative approval from the US drug regulator for generic version of Januvia.

The stock opened at Rs 886 and hit a new high of Rs 920 on NSE. The trading volumes on the counter more than doubled with a  combined 699,849 shares changing hands till 1141 hours on NSE and BSE.

On Monday, said that the US Food and Drugs Administration (USFDA) has granted its subsidiary, two tentative approvals for its Abbreviated New Drug Applications (ANDA) for generic version of Januvia, Sitagliptin tablets and generic version of Glumetza, Metformin HCl extended-release tablets.

Sitagliptin tablets have annual sales of approximately US$ 2.7 billion, while Metformin HCl Extended-release tablets have annual sales of approximately US$ 140 million in the US, it added.

Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus. Metformin HCl Extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.
 

Read more on:   
|
|

Read More

Fresenius Kabi Oncology soars on delisting plan

The promoter intends to pay an indicative price of Rs 130 per share to acquire the shares offered to it in the Delisting Offer

Quick Links

 

Market News

NCDEX reduces rental charges of warehouses

Will be applicable from 1 November

RBI lifts curbs on share purchase of ING Vysya Bank by FIIs

FIIs held 27.81% shares in the bank as of quarter ended September 30, 2014

Sesa Sterlite stock falls 3% on weak Q2 performance

Slow commissioning of projects with low return potential has been affecting the company's performance, say analysts

Banks, auto stocks top contributors in Sensex rally

Four stocks each from banking and auto sectors, information technology major Infosys and Cipla have collectively contributed nearly 470 points ...

Sensex ends at record closing high on Fed optimism, Realty reforms

The Sensex and the Nifty hit fresh record highs on Fed optimism about the US economy while the norms for FDI in construction also boosted ...

Back to Top